Evidence map›Paper›PMID 30637920›Full record

ArticleJournal of cellular and molecular medicine2019

Tumour necrosis factor-α-induced protein 8-like 2 is a novel regulator of proliferation, migration, and invasion in human rectal adenocarcinoma cells.

Dong-Dong Wu, Shi-Yu Liu, Ying-Ran Gao, Dan Lu, Ya Hong, Ya-Ge Chen, Peng-Zhen Dong, Da-Yong Wang, Tao Li, Hui-Min Li and 7 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. CystathionineOxidative medicine and cellular longevity · 2022
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Dong-Dong WuSchool of Basic Medical Sciences, Henan University College of Medicine, Kaifeng, China.ORCID 0000-0001-6739-8437
Shi-Yu LiuSchool of Basic Medical Sciences, Henan University College of Medicine, Kaifeng, China.
Ying-Ran GaoSchool of Basic Medical Sciences, Henan University College of Medicine, Kaifeng, China.
Dan LuSchool of Basic Medical Sciences, Henan University College of Medicine, Kaifeng, China.
Ya HongSchool of Basic Medical Sciences, Henan University College of Medicine, Kaifeng, China.
Ya-Ge ChenSchool of Basic Medical Sciences, Henan University College of Medicine, Kaifeng, China.
Peng-Zhen DongSchool of Basic Medical Sciences, Henan University College of Medicine, Kaifeng, China.
Da-Yong WangJoint National Laboratory for Antibody Drug Engineering, Henan International Joint Laboratory for Nuclear Protein Regulation, Henan University, Kaifeng, China.
Tao LiSchool of Basic Medical Sciences, Henan University College of Medicine, Kaifeng, China.
Hui-Min LiSchool of Basic Medical Sciences, Henan University College of Medicine, Kaifeng, China.
Zhi-Guang RenSchool of Basic Medical Sciences, Henan University College of Medicine, Kaifeng, China.
Jian-Cheng GuoCenter for Precision Medicine, Zhengzhou University, Zhengzhou, China.
Fei HeHuaihe Hospital of Henan University, Kaifeng, China.
Xue-Qun RenHuaihe Hospital of Henan University, Kaifeng, China.
Shi-Yong SunDepartment of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute, Atlanta, Georgia.
Shao-Feng DuanJoint National Laboratory for Antibody Drug Engineering, Henan International Joint Laboratory for Nuclear Protein Regulation, Henan University, Kaifeng, China.
Xin-Ying JiSchool of Basic Medical Sciences, Henan University College of Medicine, Kaifeng, China.
Henan University · CNHenan University Huaihe Hospital and Huaihe Clinical Institute · CNEmory University · USZhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tumour necrosis factor-α-induced protein 8-like 2 (TIPE2) is a tumour suppressor in many types of cancer. However, the mechanism of action of TIPE2 on the growth of rectal adenocarcinoma is unknown. Our results showed that the expression levels of TIPE2 in human rectal adenocarcinoma tissues were higher than those in adjacent non-tumour tissues. Overexpression of TIPE2 reduced the proliferation, migration, and invasion of human rectal adenocarcinoma cells and down-regulation of TIPE2 showed reverse effects. TIPE2 overexpression increased apoptosis through down-regulating the expression levels of Wnt3a, phospho (p)-β-Catenin, and p-glycogen synthase kinase-3β in rectal adenocarcinoma cells, however, TIPE2 knockdown exhibited reverse trends. TIPE2 overexpression decreased autophagy by reducing the expression levels of p-Smad2, p-Smad3, and transforming growth factor-beta (TGF-β) in rectal adenocarcinoma cells, however, TIPE2 knockdown showed opposite effects. Furthermore, TIPE2 overexpression reduced the growth of xenografted human rectal adenocarcinoma, whereas TIPE2 knockdown promoted the growth of rectal adenocarcinoma tumours by modulating angiogenesis. In conclusion, TIPE2 could regulate the proliferation, migration, and invasion of human rectal adenocarcinoma cells through Wnt/β-Catenin and TGF-β/Smad2/3 signalling pathways. TIPE2 is a potential therapeutic target for the treatment of rectal adenocarcinoma.

Indexed as

Cell MovementCell ProliferationGene Expression Regulation, NeoplasticAdenocarcinomaAdultAnimalsApoptosisBiomarkers, TumorCase-Control StudiesFemaleHumansIntracellular Signaling Peptides and ProteinsMaleMiceMice, Inbred BALB CMice, NudeBiomarkers, TumorIntracellular Signaling Peptides and ProteinsSmad2 ProteinSMAD2 protein, humanSmad3 ProteinSMAD3 protein, humanTNFAIP8L2 protein, humanTransforming Growth Factor betaapoptosisautophagyrectal adenocarcinomasignalling pathwaytumour necrosis factor-α-induced protein 8-like 2

Identifiers

PMID30637920
PMCPMC6378198
OpenAlexW2909704159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.